United States HR 2853: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2021

Status: Referred to the Subcommittee on Health. (as of 2021-04-27)

State: United States · Session: 117 · Bill: HR 2853

Sponsors: Kurt Schrader

View United States HR 2853 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.